EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    What Changes at Scale, and How Do You Know?

    A pharmaceutical process that performs reliably on a few grams of material can behave very differently at pilot or commercial scale The temperature setpoint that worked on the bench the mixing time that delivered a uniform blend the feed rate that kept a reaction on track none of these is guaranteed to mean the same thing in larger equipment When that difference goes...

KNOWLEDGE BANK

  • Articles

    From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma

    Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes

    Combination Immunotherapy Trials: Designing the Next Generation of Cancer Drugs

    For most of the past ten years the prevailing strategy in immunooncology was addition Checkpoint blockade delivered durable remissions in a minority of patients the intuitive fix was to attach a second agent to a PD or PDL backbone and watch whether response rates moved

    Impact of Continuous Manufacturing on Pharmaceutical Efficiency and Quality

    For most of its history the pharmaceutical industry has made medicines the way a bakery makes bread one batch at a time with pauses between each step for holding sampling and release testing That model served the sector well when blockbuster volumes and generous margins could absorb its inefficiencies Today neither condition holds European manufacturers face pricing pressure from payers persistent...

    Crafting Cures: The Future of Drug Manufacturing

    Behind every tablet that eases pain every vial that holds a lifesaving vaccine and every infusion that battles a chronic disease lies a complex and remarkable story It is a story of scientific discovery but more fundamentally

    The Architect of the Void: When 3D Printing Becomes the Body’s New Bone

    In the quiet pressurised hum of a modern surgical suite a surgeon holds a highdefinition scan of a young patients femur On the screen a jagged dark shadow marks where an osteosarcoma has claimed its territory For decades the script for this moment has been written in cold hard steel

    Strategic Risk Management in Pharmaceutical Supply Networks

    Ask a European pharmaceutical executive team how many qualified suppliers stand behind its ten highestvalue products and the answer arrives quickly and precisely Ask how many of those suppliers would still be shipping if a single industrial estate lost power for six weeks and the room falls silent That silence is the strategic problem in one sentence

TOP ARTICLES

  • 3

    Crafting Cures: The Future of Drug Manufacturing

    Dr. Amrish Chandra

    Drug manufacturing transforms scientific discoveries into safe, effective therapies. Emerging technologies such as continuous manufacturing, artificial intelligence, real-time monitoring, and digital...

press releases Read more...

Sino Biological Introduces AI-Trusted and Qualified Target Protein Collections for AI-Driven Discovery

As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development access to wellcharacterized target proteins is essential for evaluating AIdesigned molecules Sino Biological Inc Shenzhen Stock Exchange SZ a global biotechnology company

Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages

Sanofi announced today that the European Commission has approved VaxRabeo rabies virus inactivated strain Wistar for preexposure prophylaxis PrEP and postexposure prophylaxis PEP against rabies for all age groups

Datapharm appoints healthcare leaders to help shape the future of trusted medicines information

Datapharm the company behind emc the UKs trusted source of regulatorapproved medicines information today announced the formation of its Strategic Advisory Board bringing together senior figures from across pharma medical affairs and patient advocacy

London Biotechnology Show 2026 Concludes Two-Day Event, Bringing Global Life Sciences Community Together

The third edition of the London Biotechnology Show has concluded at ExCeL London following two days of discussions technology showcases and industry engagement that brought together stakeholders from across the global biotechnology and life sciences ecosystem

24 - 27

Nov 2026

Pharmtech & Ingredients 2026

Crocus Expo, Pavilion 2, Mosco...

24 - 25

Nov 2026

BioPharma Deals Conference 2026

Science Congress Center, Munic...

25 - 25

Nov 2026

What’s Next for Pharma Marketing in 2027

Landesmuseum Zürich, Zurich, S...

26 - 28

Nov 2026

One Health Conference 2026

Thapar Institute of Engineerin...

01 - 03

Dec 2026

Pharmaceutical Launch Excellence Summit

Novotel Amsterdam City, Nether...

01 - 03

Dec 2026

10th Antifibrotic Drug Development

Boston, MA at the Hotel Common...

02 - 04

Dec 2026

Genome Informatics 2026

Wellcome Genome Campus, UK

03 - 04

Dec 2026

LATEST NEWS Read more...

DISCO Pharmaceuticals Partners with AbbVie to Develop Next-Generation Bispecific Therapies for Solid Tumours

DISCO Pharmaceuticals has entered into a strategic collaboration and optiontolicense agreement with AbbVie to discover and develop nextgeneration ANDgated bispecific therapies for solid tumours with significant unmet medical needs

CAI Enters Agreement with PQE Group to Expand Global Life Sciences Services

CAI a professional services firm specialising in operational readiness and excellence for life sciences and other critical industries has entered into a definitive agreement with PQE Group a global consulting firm focused on quality compliance

Erasca Partners with Bristol Myers Squibb to Study ERAS-0015 Combination Therapy for Pancreatic Cancer

Erasca Inc a clinicalstage precision oncology company focused on developing treatments for cancers driven by the RASMAPK signalling pathway has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb BMS

Libtayo Receives EU Approval for Extended Dosing and Shorter Infusion Times Across Six Cancer Indications

Regeneron Pharmaceuticals has received European Commission EC approval for an alternative dosing schedule for Libtayo cemiplimab across all six of its approved indications for skin lung and cervical cancers in the European Union EU

FDA approves Roche’s Wilserdly for ER-positive, ESR1-mutated advanced breast cancer

Roche has received approval from the US Food and Drug Administration FDA for Wilserdly giredestrant in combination with everolimus to treat adults with oestrogen receptor ERpositive human epidermal growth factor receptor HERnegative ESRmutated locally advanced or metastatic breast cancer

European Commission approves Revolution Medicines’ RASONQUE for metastatic pancreatic cancer

Revolution Medicines has received European Commission EC approval for RASONQUE daraxonrasib to treat adults with metastatic pancreatic adenocarcinoma who have received at least one previous systemic therapy The medicine is taken once daily as an oral tablet and is approved for patients with or witho...